Literature DB >> 2004746

Genetic pattern of the HLA system: HLA A, B, C, DR, and DQ antigens in Mexican patients with parenchymal brain cysticercosis.

O H Del Brutto1, G Granados, O Talamas, J Sotelo, C Gorodezky.   

Abstract

The distribution of HLA class I and class II determinants was investigated in 48 patients with parenchymal neurocysticercosis and in 295 healthy controls of the same ethnic group, the Mexican Mestizo population. Two antigens, A28 and DQw2, showed significantly differences in frequency between patients and controls; HLA A28 was increased (39.6% versus 15.6%; pc = 0.008), and HLA DQw2 was decreased (4.2% versus 31.7%; pc = 0.004) in neurocysticercosis patients. The relative risk for developing the disease in HLA A28 positive individuals was 3.55. Our results show that the major histocompatibility complex plays some role in the susceptibility and resistance to parenchymal neurocysticercosis, but the HLA genetic background of patients with neurocysticercosis does not seem to influence the severity of inflammatory response against cysticerci, nor is the disease sex related.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004746

Source DB:  PubMed          Journal:  Hum Biol        ISSN: 0018-7143            Impact factor:   0.553


  9 in total

Review 1.  Molecular Neuro-Pathomechanism of Neurocysticercosis: How Host Genetic Factors Influence Disease Susceptibility.

Authors:  Naina Arora; Shweta Tripathi; Reshma Sao; Prosenjit Mondal; Amit Mishra; Amit Prasad
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

2.  Neurocysticercosis--retrospective study of autopsy reports, a 17-year experience.

Authors:  Sérgio Monteiro de Almeida; Luiz Fernando Bleggi Torres
Journal:  J Community Health       Date:  2011-10

3.  Seizure in people with newly diagnosed active or transitional neurocysticercosis.

Authors:  Elizabeth A Kelvin; Arturo Carpio; Emilia Bagiella; Denise Leslie; Pietro Leon; Howard Andrews; W Allen Hauser
Journal:  Seizure       Date:  2010-12-08       Impact factor: 3.184

Review 4.  Neurocysticercosis: current knowledge and advances.

Authors:  Wayne X Shandera; Joseph S Kass
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

5.  Symptomatic human neurocysticercosis--age, sex and exposure factors relating with disease heterogeneity.

Authors:  Agnès Fleury; Alain Dessein; Pierre Marie Preux; Michel Dumas; Graciela Tapia; Carlos Larralde; Edda Sciutto
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 6.  Human cysticercosis and Indian scenario: a review.

Authors:  Kashi Nath Prasad; Amit Prasad; Avantika Verma; Aloukick Kumar Singh
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

Review 7.  Immunodiagnosis of neurocysticercosis: ways to focus on the challenge.

Authors:  M Esquivel-Velázquez; P Ostoa-Saloma; J Morales-Montor; R Hernández-Bello; C Larralde
Journal:  J Biomed Biotechnol       Date:  2011-10-29

8.  Identification of loci controlling restriction of parasite growth in experimental Taenia crassiceps cysticercosis.

Authors:  Ruben Ramirez-Aquino; Irena Radovanovic; Anny Fortin; Edda Sciutto-Conde; Gladis Fragoso-González; Philippe Gros; Irma Aguilar-Delfin
Journal:  PLoS Negl Trop Dis       Date:  2011-12-20

Review 9.  Neurocysticercosis: A disease of neglect.

Authors:  Abhishek Mewara; Kapil Goyal; Rakesh Sehgal
Journal:  Trop Parasitol       Date:  2013-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.